Opioid Withdrawal Syndrome After Treatment With Low-Dose Extended-Release Oxycodone and Naloxone in a Gastric Cancer Patient With Portal Vein Thrombosis
- 15 May 2013
- journal article
- Published by Elsevier BV in Journal of Pain and Symptom Management
- Vol. 46 (2), e15-e17
- https://doi.org/10.1016/j.jpainsymman.2013.02.009
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- A randomized, double-blind, active-controlled, double-dummy, parallel-group study to determine the safety and efficacy of oxycodone/naloxone prolonged-release tablets in patients with moderate/severe, chronic cancer painPalliative Medicine, 2011
- High doses of oxycodone–naloxone combination may provide poor analgesiaSupportive Care in Cancer, 2011
- Prolonged-release naloxone can cause systemic opioid withdrawalEuropean journal of pain, 2009
- A randomised controlled trial with prolonged‐release oral oxycodone and naloxone to prevent and reverse opioid‐induced constipationEuropean journal of pain, 2009
- Oxycodone for Cancer-Related PainArchives of Internal Medicine, 2006
- Comparison of sustained-release morphine with sustained-release oxycodone in advanced cancer patientsBritish Journal of Cancer, 2003
- Low-Dose Oral Naloxone Reverses Opioid-Induced Constipation and AnalgesiaJournal of Pain and Symptom Management, 2002
- An investigation of the ability of oral naloxone to correct opioid-related constipation in patients with advanced cancerPalliative Medicine, 1996
- NaloxoneAnnals of Emergency Medicine, 1983